Next Generation Probiotics Services for Cardiovascular Disease

Modifying gut microbiota with probiotics has been in practice for centuries and is now being studied in the treatment and prophylaxis for cardiovascular disease (CVD). As a leading specialist in live biotherapeutics drug discovery, Creative Biolabs has developed a cutting-edge platform for the identification, characterization, and development of next-generation probiotics (NGPs). We are committed to providing overall solutions to facilitate our customers’ NGPs project development. Next Generation Probiotics Services for Cardiovascular Disease https://live-biotherapeutic.creative-biolabs.com/cardiovascular-disease.htm